Journey Medical (DERM) Free Cash Flow Growth (1y) (2021 - 2026)
Journey Medical (DERM) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 44.93% |
| 10 | Journey Medical | 171.48 Mn | 144.26 Mn | 9.70 Mn | 202.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202.72% |
| Dec 31, 2025 | -382.43% |
| Sep 30, 2025 | -105.96% |
| Jun 30, 2025 | 81.80% |
| Mar 31, 2025 | 43.57% |
| Dec 31, 2024 | 113.47% |
| Sep 30, 2024 | -106.17% |
| Jun 30, 2024 | -230.41% |
| Mar 31, 2024 | 15.73% |
| Dec 31, 2023 | -330.66% |
| Sep 30, 2023 | 357.44% |
| Jun 30, 2023 | 220.27% |
| Mar 31, 2023 | 68.84% |
| Dec 31, 2022 | -19.65% |
| Sep 30, 2022 | -202.53% |
| Jun 30, 2022 | 55.63% |
| Mar 31, 2022 | -1,504.56% |
| Dec 31, 2021 | -452.70% |